on Fresenius Medical Care AG & Co. KGaA (ETR:FME)
Fresenius Medical Care AG Announces CEO Change
On October 7, 2026, Fresenius Medical Care AG announced a significant leadership change. The Supervisory Board appointed Shervin J. Korangy as the new Chairman of the Management Board, effective October 12, 2026. Korangy, who has resigned from the Supervisory Board, will succeed Helen Giza. Giza, who has served as Chairwoman, will depart the company on October 11, 2026. The Board expressed gratitude for her contributions.
This change marks an important transition for the company, as it looks towards new leadership to drive future growth. The announcement follows Article 17 MAR of the EU Regulation, ensuring transparency to stakeholders.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Fresenius Medical Care AG & Co. KGaA news